Christopher Mueller

Entrepreneurial Technology Executive | CTO/VP/Director | Scientific and High-Performance Computing | Life Sciences

Austin, Texas, United States

About

Experienced technology executive and entrepreneur with a focus on transformative informatics solutions for the life sciences. Dynamic leader with a proven track record of developing strategies and solutions along with the teams necessary to successfully execute complex technology-driven projects. Leadership Specialties * Strategic Planning: business plans, product roadmaps, digital transformation * Team Building: interviewing, hiring, and mentoring to build and retain high-performing teams * Partner and Client Management: influencing, negotiating, execution, and support * Budgeting: defining and adhering to budgets at different levels in an organization * Sales and Marketing: to customers, investors, and partners * Fundraising: VC, private equity, grants, strategic partnerships, internal funds * Agile Development: bookended with clear requirements and comprehensive QA Technology Specialties * Full stack software architecture and engineering * Scientific computing, high-performance computing and data visualization, with a focus on bioinformatics * Database design and development (Oracle, PostgreSQL, MySQL, sqlite) * System architecture, design and deployment of compute clusters and cloud solutions * Proficient in Python, C/C++, SQL, JavaScript

Experience

  • CTO and Principal Scientific Consultant at Boulder BioConsulting, Inc.
    Jan 2020 - Present · 6 yrs 6 mos

    At BBC, I've been driving our transition from pure services to a blended product/services model. Our "Informatics as a Service" approach provides strategic and tactical support to early stage life science companies as they evolve their software and data systems. Our clients have helped us identify gaps in the software ecosystem where we can provide targeted solutions that provide value across our customer base, leading to the development of multiple products that provide solutions for tool deployment, data transformation, and lab management.

  • Consultant at Life Science/Informatics Consultant
    Sep 2019 - Present · 6 yrs 10 mos

    Independent consultant providing strategic and tactical services for early and growth stage life science companies with a focus on developing informatics strategies for products and organizations that leverage the latest advances in bioinformatics, AI/ML, and HPC/Cloud infrastructure.

  • Consultant at Erisyon
    Jan 2020 - Apr 2021 · 1 yr 4 mos

    I worked with the Erisyon team to develop early stage product strategy and contributed to the signal processing and data science efforts for their novel fluorescent imaging-based single molecule protein sequencing platform.

  • VP, Life Sciences Solutions Group at Enthought
    Aug 2018 - Sep 2019 · 1 yr 2 mos

    At Enthought, I was responsible for defining and building the company’s life science digital transformation business. During my tenure, I have doubled the size of the life science consulting team, increased engagement with existing customers by 50%, established a sales pipeline, and worked directly with international clients to define and execute digital transformation strategies.

  • President and CTO, Founder at L7 Informatics
    Apr 2012 - Jul 2018 · 6 yrs 4 mos

    I founded L7 (previously Lab7) to provide transformative solutions for data-intensive laboratory applications, with a focus on genomics. As the President and CTO, I was responsible for building the company and providing the technological and scientific vision. The company launched two product lines: the Enterprise Science Platform (ESP), a sample-to-answer lab and analysis automation platform, and BioBuilds, a curated and compiled collection of open source bioinformatics tools. In addition to acquiring customers spanning government, pharmaceuticals, agriculture and health care, the company developed partnerships with most major cloud and hardware providers and launched a dedicated Genomic Cloud solution with IBM. Prior to an exit to a private equity group, I raised $3.5M and grew the company to nearly 20 employees with $1M+ in revenue.